Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation
In this study, we used comparative genomics and developmental genetics to identify epigenetic regulators driving oncogenesis in a zebrafish ( ) somatic-targeting model of RB1 mutant embryonal brain tumors. Zebrafish brain tumors caused by TALEN or CRISPR targeting are histologically similar to human...
Saved in:
Published in | Disease models & mechanisms Vol. 11; no. 6 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
The Company of Biologists Ltd
01.06.2018
The Company of Biologists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this study, we used comparative genomics and developmental genetics to identify epigenetic regulators driving oncogenesis in a zebrafish
(
) somatic-targeting model of RB1 mutant embryonal brain tumors. Zebrafish
brain tumors caused by TALEN or CRISPR targeting are histologically similar to human central nervous system primitive neuroectodermal tumors (CNS-PNETs). Like the human oligoneural
CNS-PNET subtype, zebrafish
tumors show elevated expression of neural progenitor transcription factors
,
,
and the receptor tyrosine kinase
oncogene. Comparison of
tumor and
germline mutant larval transcriptomes shows that the altered oligoneural precursor signature is specific to tumor tissue
More than 170 chromatin regulators were differentially expressed in
tumors, including overexpression of chromatin remodeler components
(
) and
(
). Germline mutant analysis confirms that zebrafish
,
and
are required during brain development.
is necessary for neural precursor cell cycle exit and terminal differentiation,
is required for survival of postmitotic precursors, and
maintains proliferation of the neural stem cell/progenitor pool. We present an
assay using somatic CRISPR targeting plus live imaging of histone-H2A.F/Z-GFP fusion protein in developing larval brain to rapidly test the role of chromatin remodelers in neural stem and progenitor cells. Our somatic assay recapitulates germline mutant phenotypes and reveals a dynamic view of their roles in neural cell populations. Our study provides new insight into the epigenetic processes that might drive pathogenesis in RB1 brain tumors, and identifies Rbbp4 and its associated chromatin remodeling complexes as potential target pathways to induce apoptosis in RB1 mutant brain cancer cells.This article has an associated First Person interview with the first author of the paper. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Recombinetics, Inc., St. Paul, MN 55104, USA. |
ISSN: | 1754-8403 1754-8411 |
DOI: | 10.1242/dmm.034124 |